These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8892659)

  • 21. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
    Ali A; Ng HL; Dagarag MD; Yang OO
    Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
    Couillin I; Letourneur F; Lefèbvre P; Guillet JG; Martinon F
    Virology; 2001 Jan; 279(1):136-45. PubMed ID: 11145897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
    Evans DT; O'Connor DH; Jing P; Dzuris JL; Sidney J; da Silva J; Allen TM; Horton H; Venham JE; Rudersdorf RA; Vogel T; Pauza CD; Bontrop RE; DeMars R; Sette A; Hughes AL; Watkins DI
    Nat Med; 1999 Nov; 5(11):1270-6. PubMed ID: 10545993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
    APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein.
    Dupuis M; Kundu SK; Merigan TC
    J Immunol; 1995 Aug; 155(4):2232-9. PubMed ID: 7543542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
    Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
    J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population.
    Furutsuki T; Hosoya N; Kawana-Tachikawa A; Tomizawa M; Odawara T; Goto M; Kitamura Y; Nakamura T; Kelleher AD; Cooper DA; Iwamoto A
    J Virol; 2004 Aug; 78(16):8437-45. PubMed ID: 15280452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
    J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
    Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T
    Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; Sigmund K; Bangham CR
    Nature; 1995 Jun; 375(6532):606-11. PubMed ID: 7791879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturally arising HIV-1 Nef variants conferring escape from cytotoxic T lymphocytes influence viral entry co-receptor expression and susceptibility to superinfection.
    Mwimanzi P; Hasan Z; Tokunaga M; Gatanaga H; Oka S; Ueno T
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):422-7. PubMed ID: 21093412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein.
    Choppin J; Martinon F; Connan F; Gomard E; Levy JP
    J Immunol; 1991 Jul; 147(2):569-74. PubMed ID: 1712811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.
    Couillin I; Culmann-Penciolelli B; Gomard E; Choppin J; Levy JP; Guillet JG; Saragosti S
    J Exp Med; 1994 Sep; 180(3):1129-34. PubMed ID: 7520468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
    Klenerman P; Meier UC; Phillips RE; McMichael AJ
    Eur J Immunol; 1995 Jul; 25(7):1927-31. PubMed ID: 7542596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
    Robertson MN; Buseyne F; Schwartz O; Rivière Y
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs.
    Ueno T; Idegami Y; Motozono C; Oka S; Takiguchi M
    J Immunol; 2007 May; 178(9):5513-23. PubMed ID: 17442933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.